Home
Site Map
Investors
Press Releases
Contact Us
Clinical Trials
Phase III — Hepatocellular Carcinoma (HCC)
Phase III — Metastatic Colorectal Cancer (MCRC)
Phase I — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Glioma
Benign Prostatic Hyperplasia (BPH)
Litx™ Therapy
Litx™ Advantages
Publications
The Company
Executive Team
Board of Directors
Scientific Advisory Board
Careers
Contact LSO
The Company
Executive Team
Llew Keltner
Jay Winship
James Chen
Robert Littauer
Sy-Shi Wang
Erik Hagstrom
Board of Directors
Scientific Advisory Board
Careers
Contact LSO
Executive Team
Llew Keltner
President, CEO and Director
Jay Winship
Chief Medical Officer
James Chen
Chief Scientific Officer
Robert Littauer
VP Chief Financial Officer
Sy-Shi Wang
VP Clinical Development
Erik Hagstrom
VP Engineering